Van Eyk, Dunn - Proteomic and Genomic Analysis of Cardiovascular Disease - 2003 (522919), страница 16
Текст из файла (страница 16)
E.Sudden death in young athletes. Circulation. 1980, 62, 218–229.Thierfelder, L., Watkins, H., MacRae,C., Lamas, R., McKenna, W., et al. Alpha-tropomyosin and cardiac troponin Tmutations cause familial hypertrophiccardiomyopathy: a disease of the sarcomere. Cell. 1994, 77, 701–712.2.7 References910111213141516171819Poetter, K., Jiang, H., Hassanzadeh, S.,Master, S. R., Chang, A., et al. Mutationsin either the essential or regulatory lightchains of myosin are associated with a raremyopathy in human heart and skeletalmuscle. Nat. Genet. 1996, 13, 63–69.Sanbe, A., Nelson, D., Gulick, J., Setser, E., Osinska, H., et al.
In vivo analysis of an essential myosin light chainmutation linked to familial hypertrophiccardiomyopathy. Circ. Res. 2000, 87, 296–302.Liang, P., Pardee, A. B. Differential display of eukaryotic messenger RNA bymeans of the polymerase chain reaction.Science. 1992, 257, 967–971.Dempsey, A. A., Dzau, V. J., Liew, C. C.Cardiovascular genomics: estimating thetotal number of genes expressed in thehuman cardiovascular system. J. Mol.Cell. Cardiol.
2001, 33, 1879–1886.Liew, C. C., Hwang, D. M., Wang, R. X.,Ng, S. H., Dempsey, A., et al. Construction of a human heart cDNA library andidentification of cardiovascular basedgenes (CVBest). Mol. Cell. Biochem. 1997,172, 81–87.Velculescu, V. E., Zhang, L., Vogelstein, B., Kinzler, K. W. Serial analysisof gene expression. Science. 1995, 270,484–487.James, J., Osinska, H., Hewett, T. E.,Kimball, T., Klevitsky, R., et al. Transgenic over-expression of a motor proteinat high levels results in severe cardiacpathology. Transgenic Res.
1999, 8, 9–22.Seidman, J. G., Seidman, C. The geneticbasis for cardiomyopathy: from mutationidentification to mechanistic paradigms.Cell. 2001, 104, 557–567.Izumo, S., Shioi, T. Cardiac transgenicand gene-targeted mice as models of cardiac hypertrophy and failure: a problemof (new) riches. J.
Card. Fail. 1998, 4,263–270.James, J., Robbins, J. Molecular remodeling of cardiac contractile function. Am. J.Physiol. 1997, 273, H2105–2118.Gulick, J., Hewett, T. E., Klevitsky, R.,Buck, S. H., Moss, R. L., et al. Transgenicremodeling of the regulatory myosinlight chains in the mammalian heart.Circ. Res. 1997, 80, 655–664.2021222324252627282930Subramaniam, A., Gulick, J., Neumann, J., Knotts, S., Robbins, J. Transgenic analysis of the thyroid-responsiveelements in the alpha-cardiac myosinheavy chain gene promoter. J.
Biol.Chem. 1993, 268, 4331–4336.Tsien, J. Z., Chen, D. F., Gerber, D.,Tom, C., Mercer, E. H., et al. Subregionand cell type-restricted gene knockout inmouse brain. Cell. 1996, 87, 1317–1326.Costantini, F., Radice, G., Lee, J. L.,Chada, K. K., Perry, W., et al. Insertionalmutations in transgenic mice. Prog. Nucleic Acids Res. Mol. Biol. 1989, 36, 159–169.Krulewski, T. F., Neumann, P. E., Gordon, J. W. Insertional mutation in atransgenic mouse allelic with Purkinjecell degeneration.
Proc. Natl. Acad. Sci.USA. 1989, 86, 3709–3712.Singh, G., Supp, D. M., Schreiner, C.,McNeish, J., Merker, H. J., et al. leglessinsertional mutation: morphological, molecular, and genetic characterization.Genes Dev. 1991, 5, 2245–2255.Doetschman, T., Gregg, R. G., Maeda,N., Hooper, M. L., Melton, D. W., et al.Targetted correction of a mutant HPRTgene in mouse embryonic stem cells.
Nature. 1987, 330, 576–578.Valancius, V., Smithies, O. Testing an“in-out” targeting procedure for makingsubtle genomic modifications in mouseembryonic stem cells. Mol. Cell. Biol.1991, 11, 1402–1408.Minamino, T., Gaussin, V., DeMayo, F. J.,Schneider, M. D. Pre-selection of integration sites imparts repeatable transgeneexpression. Circ. Res. 2001, 88, 587–592.Wallace, H., Ansell, R., Clark, J.,McWhir, J. Pre-selection of integrationsites imparts repeatable transgene expression. Nucleic Acids Res.
2000, 28, 1455–1464.Kuo, H. C., Cheng, C. F., Clark, R. B.,Lin, J. J. C., Lin, J. L. C., et al. A defect inthe Kv channel-interacting protein 2(KChIP2) gene leads to a complete lossof I(to) and confers susceptibility to ventricular tachycardia. Cell. 2001, 107, 801–813.Feiner, L., Webber, A. L., Brown, C. B.,Lu, M. M., Jia, L., et al. Targeted disrup-41422 Cardiac Disease and The Transcriptome31323334353637383940tion of semaphorin 3C leads to persistenttruncus arteriosus and aortic arch interruption. Development. 2001, 128, 3061–3070.Feil, R., Brocard, J., Mascrez, B., LeMeur, M., Metzger, D., et al.
Ligand-activated site-specific recombination inmice. Proc. Natl. Acad. Sci. USA. 1996,93, 10887–10890.Sohal, D. S., Nghiem, M., Crackower,M. A., Witt, S. A., Kimball, T. R., et al.Temporally regulated and tissue-specificgene manipulations in the adult and embryonic heart using a tamoxifen-inducibleCre protein. Circ. Res. 2001, 89, 20–25.Gossen, M., Freundlieb, S., Bender,G., Muller, G., Hillen, W., et al.
Transcriptional activation by tetracyclines inmammalian cells Science. 1995, 268,1766–1769.Fazio, S., Linton, M. F. Mouse modelsof hyperlipidemia and atherosclerosis.Front. Biosci. 2001, 6, D515–525.Taddei, I., Morishima, M., Huynh, T.,Lindsay, E. A. Genetic factors are majordeterminants of phenotypic variability ina mouse model of the DiGeorge/del22q11 syndromes. Proc. Natl. Acad.Sci. USA. 2001, 98, 11428–11431.Nerbonne, J. M., Nichols, C.
G.,Schwarz, T. L., Escande, D. Genetic manipulation of cardiac K(+) channel function in mice: what have we learned, andwhere do we go from here? Circ. Res.2001, 89, 944–956.Valenza-Schaerly, P., Pickard, B., Walter, J., Jung, M., Pourcel, L., et al. Adominant modifier of transgene methylation is mapped by QTL analysis tomouse chromosome 13. Genome Res.2001, 11, 382–388.Montagutelli, X. Effect of the geneticbackground on the phenotype of mousemutations.
J. Am. Soc. Nephrol. 2000, 11Suppl 16, S101–105.Molkentin, J. D., Lu, J. R., Antos, C. L.,Markham, B., Richardson, J., et al. Acalcineurin-dependent transcriptionalpathway for cardiac hypertrophy. Cell.1998, 93, 215–228.Periasamy, M., Strehler, E. E., Garfinkel, L.
I., Gubits, R. M., Ruiz-Opazo, N.,et al. Fast skeletal muscle myosin light41424344454647484950chains 1 and 3 are produced from a single gene by a combined process of differential RNA transcription and splicing. J.Biol. Chem. 1984, 259, 13595–13604.Yang, J., Moravec, C. S., Sussman,M. A., DiPaola, N. R., Fu, D., et al. Decreased SLIM1 expression and increasedgelsolin expression in failing humanhearts measured by high-density oligonucleotide arrays. Circulation. 2000, 102,3046–3052.Paoni, N.
F., Lowe, D. G. Expression profiling techniques for cardiac molecularphenotyping. Trends Cardiovasc. Med.2001, 11, 218–221.Streicher, J., Donat, M. A., Strauss, B.,Sporle, R., Schughart, K., et al. Computer-based three-dimensional visualization of developmental gene expression.Nat. Genet. 2000, 25, 147–152.Arnone, M. I., Davidson, E. H.
Thehardwiring of development: organizationand function of genomic regulatory systems. Development. 1997, 124, 1851–1864.Newton, M. A., Kendziorski, C. M.,Richmond, C. S., Blattner, F. R., Tsui,K. W. On differential variability of expression ratios: improving statistical inference about gene expression changesfrom microarray data.
J. Comput. Biol.2001, 8, 37–52.Hwang, J. J., Dzau, V. J., Liew, C. C.Genomics and the pathophysiology ofheart failure. Curr. Cardiol. Rep. 2001, 3,198–207.Stanton, L. W., Garrard, L. J., Damm,D., Garrick, B. L., Lam, A., et al. Alteredpatterns of gene expression in responseto myocardial infarction. Circ. Res. 2000,86, 939–945.Aronow, B. J., Toyokawa, T., Canning,A., Haghighi, K., Delling, U., et al. Divergent transcriptional responses to independent genetic causes of cardiac hypertrophy. Physiol. Genomics. 2001, 6, 19–28.Zong, Q., Schummer, M., Hood, L.,Morris, D. R. Messenger RNA translation state: the second dimension of highthroughput expression screening.
Proc.Natl. Acad. Sci. USA. 1999, 96, 10632–10636.Schwartzbauer, G., Robbins, J. The tumor suppressor gene PTEN can regulate2.7 References515253545556575859cardiac hypertrophy and survival. J. Biol.Chem. 2001, 276, 35786–35793.Kudej, R. K., Iwase, M., Uechi, M., Vatner, D. E., Oka, N., et al. Effects ofchronic beta-adrenergic receptor stimulation in mice. J. Mol. Cell. Cardiol. 1997,29, 2735–2746.Perrella, M. A., Maki, T., Prasad, S., Pimental, D., Singh, K., et al.
Regulationof heparin-binding epidermal growth factor-like growth factor mRNA levels by hypertrophic stimuli in neonatal and adultrat cardiac myocytes. J. Biol. Chem. 1994,269, 27045–27050.Takemoto, Y., Yoshiyama, M., Takeuchi,K., Omura, T., Komatsu, R., et al.
Increased JNK, AP-1 and NF-kappa B DNAbinding activities in isoproterenol-induced cardiac remodeling. J Mol. Cell.Cardiol. 1999, 31, 2017–2030.Moraru, II, Syrbu, S., Michaels, K.,Kim, D. H., Malchoff, D., et al. Pressure overload induces overexpression ofannexins II and V in aortic-banded rats.Ann.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
